Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INOVATYON: Trabectedin + PLD vs Carboplatin + PLD in Recurrent Ovarian Cancer
NCT01379989Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jun 2011
- Primary completion
- Dec 2020
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of trabectedin in ovarian cancer, sponsored by Mario Negri Institute for Pharmacological Research. Started Jun 2011; status: completed.
02
Drugs
trabectedin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01379989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01379989.